Carindacillin (Carbenicillin indanyl) sodium is an orally active and broad-spectrum antimicrobial agent. Carindacillin sodium can be hydrolyzed to Carbenicillin in vivo. Carindacillin sodium can be used for the research of urinary-tract infection.

Carindacillin sodium is active against a broad spectrum of bacterial species in vitro[1].

Carindacillin sodium (p.o.) protects mice against lethal infections produced by Escherichia coli , Salmonella choleraesuis , Pasteurella multocida , Proteus vulgaris , Staphylococcus aureus , and Streptococcus pyogenes , with PD 95 s ranging from 30.4 mg/kg to 220.4 mg/kg[1].

26605-69-6

C26H26N2NaO6S

517.55

Carbenicillin indanyl sodium;CP-15464-2;Carindacillin sodium;Carindacillin sodium

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years